Electrospray ionisation: difference between revisions
Diff·revision 17 → 18·18:23, 19 Aug 2025
Difference between revision 17 and revision 18 of Electrospray ionisation. 3 lines changed; the page grew by 250 bytes.
| Revision 17 — 13:51, 18 Jul 2025 Retention_Time_Rae (talk) correct the resolution formula — the denominator is the sum of the widths 4,073 bytes ±0 | Revision 18 — 18:23, 19 Aug 2025 HyphenHarriet (talk) add the sample preparation, since the result depends on it 4,323 bytes +250 | ||
|---|---|---|---|
| 34 | Poorly ionising species may be absent from a spectrum while present in the material, so absence from the spectrum is not absence from the sample.{{r|usp1503}} | 34 | Poorly ionising species may be absent from a spectrum while present in the material, so absence from the spectrum is not absence from the sample.{{r|usp1503}} |
| 35 | 35 | ||
| + | 36 | These are properties of the technique rather than observations about any supplier or laboratory.{{r|reports}} | |
| + | 37 | ||
| 36 | == References == | 38 | == References == |
| 37 | {{reflist}} | 39 | {{reflist}} |
| ⋮ | ⋮ | ||
| 39 | <ref name="aebersold2003">Aebersold R, Mann M. "Mass spectrometry-based proteomics." ''Nature'' 422(6928):198–207 (2003). PMID 12634793.</ref> | 41 | <ref name="aebersold2003">Aebersold R, Mann M. "Mass spectrometry-based proteomics." ''Nature'' 422(6928):198–207 (2003). PMID 12634793.</ref> |
| 40 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 42 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| + | 43 | <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> | |
| 41 | 44 | ||
| 42 | == See also == | 45 | == See also == |